News

"VAAST" software could spot disease genes

Forbes' Matthew Herper reported that National Human Genome Research Institute recently posted a graphic on Twitter that shows the cost of whole genome sequencing has been falling at a greater pace

My visit to Nimbus, Bill Gates' bet on virtual drug discovery

The nerve center of Nimbus Discovery, a largely virtual biotech start-up, resides in the offices of Atlas Venture in Cambridge, MA. Bruce Booth, an Atlas partner and chairman of the small company,

Report: SAS hatches new "think tank" for life sciences, healthcare analytics

SAS has begun to recruit fresh brains for a new "think tank" focused on serving the Cary, NC-based business analytics giant's healthcare and life sciences customers, The News & Observer reported

Medidata Solutions' revenue up, CEO notes rival's integration issues

Medidata ($MDSO) is gaining steam in the market for clinical trials software, even though its first-quarter revenue came in just short of some analysts' expectations. It's been interesting to watch

Merge Healthcare part of "virtual" lab for cancer trial

Merge Healthcare ($MRGE) is gaining more traction in its clinical software business. The Chicago-based company says that its clinical image management software will be used in an upcoming trial

David Shaw goes from high finance to high-tech biotech simulations

Forbes blogger Tom Groenfeldt ordinarily writes about financial technology, but the worlds of hedge fund technology and computational biochemistry collide in David Shaw, founder of D.E. Shaw fund

Scientists create 'schizophrenic' computer network to understand the disease

A lot of information passes through our brains, and most of us have a natural ability to filter out what is important for us to remember immediately and what can be filed away for later use--or

PerkinElmer acquires Geospiza, recognizes importance of genomic information

Xconomy's Luke Timmerman explains why life science toolmaking giant PerkinElmer decided to acquire Seattle bioinformatics business Geospiza, despite the fact that the acquisition will have "minimal

Open source drug discovery for the developing world

Lori Mehen, an account manager at Red Hat, writes in opensource.com that the future of pharma is open source--particularly when it comes to drug development for the developing world. She mentions, in

Computational biology explains anti-cancer side-effect of HIV drug

Philip Bourne of the University of California, San Diego, was curious as to why the anti-HIV drug nelfinavir had a surprisingly beneficial side-effect. It also reduced tumors in a variety of cancers.

New computational models help solve protein mysteries

The importance of computational modeling of molecules for drug design and disease research is illustrated in a new paper appearing in Nature that outlines a new method of solving several baffling

Social networks say they have vital info to add to clinical trials

The Wall Street Journal's Health blog follows up on last week's news that PatientsLikeMe, a Cambridge, MA company, is using its social network to complement clinical trials with real-world case

Computer models aid fight against flu

Reporting from the International Conference on Innovations in Information Technology at the United Arab Emirates University, The National wrote about how Dr. Vittoria Colizza of the ISI Foundation in

MIT invents software for building DNA structures

A select few scientists have dazzled their peers by using DNA to build two-dimensional and complex three-dimensional structures that hold lots of promise in the fields of medicine and synthetic

New tech helping labs go virtual

Advanced scientific tools like high-powered telescopes and DNA sequencing systems have provided researchers with a tsunami of data to interpret. Well, many large computers are actually doing much of

How can IBM's Watson aid pharma researchers?

You might know about how IBM's Watson supercomputer bested human contestants in the game show Jeopardy! in February. But there's also been some thought about what the supercomputer could do to aid

PatientsLikeMe study challenges prior ALS claims

PatientsLikeMe is making some waves in the research world about the potential of its patient social network to provide insights into the health of people with serious diseases. The Cambridge,

Study: EMRs could aid in disease research

With the U.S. rapidly adopting electronic health records, there's a big opportunity to use data from the records to aid in disease research. Researchers at Northwestern University showed that tapping

"Biopunk" illuminates world of bio-hackers

In "Biopunk: DIY Scientists Hack the Software of Life," journalist Markus Wohlsen brings to light the efforts of do-it-yourself biotech inventors who are making use of such technologies as cheap DNA

Informatics firm Humedica raises $20M

Humedica, which offers clinical informatics to life sciences companies and other healthcare customers, has raised $20 million in what appears to be a second round of equity financing, according to an